We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 489.00
Bid: 488.00
Ask: 490.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.41%)
Open: 489.00
High: 489.00
Low: 489.00
Prev. Close: 489.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update - Nexus Underwriting

24 Feb 2020 07:00

RNS Number : 7858D
B.P. Marsh & Partners PLC
24 February 2020
 

24 February 2020

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

Investee Company Update - Nexus Underwriting Management Limited

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist investor in early stage financial services businesses, is delighted to announce that its investee company, Nexus Underwriting Management Limited ("Nexus") has launched a new Financial Lines division in Chicago, United States, under its newly formed entity, Nexus Specialty Inc. ("Nexus Specialty"). 

 

Nexus Specialty's Financial Lines division has A-Rated underwriting capacity, provided by Profession Solutions Insurance Company ("PSIC"), rated "A" (Excellent) by A.M. Best.

 

The new Financial Lines division will be led by Stacy Paquet, a highly regarded leader in the Management Liability sector in the United States. Ms. Paquet has over 15 years' experience in this sector of the insurance market and was previously President of Management Liability at OneBeacon Insurance Group, based in Chicago. Ms. Paquet has extensive distribution relationships, which will build on Nexus' successful, long-term presence in the Financial Lines space in the UK.

 

The Group holds an aggregate Nexus shareholding of 17.7% and has been invested since August 2014. Nexus is one of the largest independently owned Managing General Agencies in the UK insurance market, budgeting to write over £345m of Gross Written Premium across various specialty lines in the 2020 financial year, including Trade Credit, Marine and Aviation insurance. Nexus has eight overseas offices across Europe, America and Asia.

 

Adam Kembrooke, Chief Executive Officer and President, Nexus Specialty, Inc. said: "We have ambitious plans to grow in the specialty insurance market in the US and are committed to replicating the success Nexus Group has already had in the UK and Europe. As a Group, we were founded as a Financial Lines MGA and already have a tremendous reputation and track record in this sector - I am delighted to have Stacy join us and to have such a great carrier partner in PSIC to continue building on that success in the US."

 

Dan Topping, B.P. Marsh's Chief Investment Officer and Nominee Director on the Board of Nexus has said: "B.P. Marsh is pleased to announce that Nexus has further expanded its Financial Lines product offering with this addition in North America, further emphasising Nexus as a global specialty lines MGA."

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE / Harriett Osmond - Investor Relations

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon (UK) Limited

Atholl Tweedie / Charles Leigh-Pemberton / Ailsa Macmaster

+44 (0)20 7886 2500

 

Financial PR

Tavistock Communications Limited

Simon Hudson / Tim Pearson

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

Since formation over 25 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

Since its inception B.P. Marsh has delivered an average annual compound increase in NAV of over 10% and this remains one of the Group's core goals for future years.

- Ends -

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFLFLSFLILFII
Date   Source Headline
16th Apr 202412:45 pmRNSInvestee Company Update – LEBC Holdings
12th Apr 202411:01 amRNSAward of Shares under Share Incentive Plan
9th Apr 20249:45 amRNSInvestment Update – Pantheon Specialty Limited
8th Apr 20243:07 pmRNSTransfer of Treasury Shares
27th Mar 202412:20 pmRNSInvestment – Devonshire UW Limited
25th Mar 20247:00 amRNSCompletion of Sale and Dividend Declaration
22nd Feb 202410:49 amRNSDirector/PDMR Shareholding
19th Feb 20244:05 pmRNSDirector/PDMR Shareholding
19th Feb 20247:00 amRNSTrading Update
16th Feb 20244:13 pmRNSDirector/PDMR Shareholding
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
13th Feb 20241:52 pmRNSHolding(s) in Company
9th Feb 20249:25 amRNSDirector/PDMR Shareholding
7th Feb 20243:00 pmRNSInterim Dividend Declaration
6th Feb 202412:31 pmRNSDirector/PDMR Shareholding
23rd Jan 20242:23 pmRNSUse of Proceeds of Sale and Strategy Confirmation
4th Jan 20244:35 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:25 amRNSInvestment – Ai Marine Risk Limited
27th Dec 20237:00 amRNSCorrection - PDMR and Director Dealings
8th Dec 20235:15 pmRNSDirector/PDMR Shareholding
7th Dec 20237:23 amRNSRealisation of Investment
4th Dec 202310:58 amRNSTransaction in Own Shares
30th Nov 202312:56 pmRNSTransaction in Own Shares
29th Nov 20232:29 pmRNSTransaction in Own Shares
27th Nov 202312:48 pmRNSTransaction in Own Shares
24th Nov 20234:15 pmRNSTransaction in Own Shares
23rd Nov 20234:55 pmRNSTransaction in Own Shares
20th Nov 202312:35 pmRNSFurther Information re Share Option Plan
20th Nov 202311:44 amRNSTransaction in Own Shares
15th Nov 20235:33 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSShares Cancellation & New Share Buy-Back Programme
13th Nov 20239:42 amRNSInvestee Company Update disposal by LEBC of Aspira
20th Oct 20236:23 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSHalf-Year Results
11th Oct 20234:05 pmRNSNotice of Half Year Results
10th Oct 20237:00 amRNSCompletion of Sale of Kentro Capital Limited
2nd Oct 202312:05 pmRNSTransaction in Own Shares
25th Sep 202310:28 amRNSTransaction in Own Shares
19th Sep 20233:50 pmRNSTransaction in Own Shares
18th Sep 202311:18 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTrading Statement
14th Sep 20232:49 pmRNSTransaction in Own Shares
11th Sep 20234:29 pmRNSTransaction in Own Shares
7th Sep 20235:32 pmRNSTransaction in Own Shares
5th Sep 20234:24 pmRNSTransaction in Own Shares
4th Sep 20232:48 pmRNSTransaction in Own Shares
1st Sep 20233:13 pmRNSTransaction in Own Shares
30th Aug 20231:58 pmRNSTransaction in Own Shares
29th Aug 20239:03 amRNSTransaction in Own Shares
24th Aug 202312:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.